Cytokinetics Ownership 2024 | Who Owns Cytokinetics Now?
Institutional Ownership
59.09%
Insider Ownership
0.51%
Retail Ownership
40.41%
Institutional Holders
217.00
Cytokinetics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 14.40% | 0.02% | 14,672,779 | 2,258,006 | 18.19% | 794,971,166 | Jun 30, 2024 |
| FMR LLC | 11.31% | 0.04% | 11,523,128 | 621,985 | 5.71% | 624,323,102 | Jun 30, 2024 |
| VANGUARD GROUP INC | 11.22% | 0.01% | 11,437,696 | 1,440,620 | 14.41% | 619,694,370 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 7.99% | 0.28% | 8,138,677 | 3,017,088 | 58.91% | 440,954,000 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 7.37% | 0.07% | 7,509,530 | 3,528,070 | 88.61% | 406,866,335 | Jun 30, 2024 |
| STATE STREET CORP | 6.42% | 0.02% | 6,548,536 | 2,028,178 | 44.87% | 354,799,680,000 | Jun 30, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 4.49% | 28.63% | 4,575,558 | 4,575,558 | 100.00% | 246,073,509 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 4.30% | 0.02% | 4,380,769 | -396,859 | -8.31% | 237,350,064 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.69% | 0.01% | 2,738,646 | 491,481 | 21.87% | 148,408,055 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 2.67% | 2.28% | 2,721,158 | 196,078 | 7.77% | 147,432,340 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 2.41% | 0.78% | 2,454,665 | 849,089 | 52.88% | 132,993,750 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.31% | 0.02% | 2,358,343 | -572,605 | -19.54% | 127,776,000 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 2.06% | 5.99% | 2,100,000 | - | - | 113,778,000 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 2.04% | 8.38% | 2,075,000 | -75,000 | -3.49% | 112,423,500 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 2.03% | 1.41% | 2,065,991 | 540,303 | 35.41% | 111,935,392 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 1.84% | 0.04% | 1,879,161 | 109,096 | 6.16% | 101,812,943 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.73% | 0.11% | 1,768,162 | 14,516 | 0.83% | 95,797,222 | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | 1.72% | 4.71% | 1,757,192 | - | - | 95,204,663 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.65% | 0.12% | 1,678,159 | -878,644 | -34.36% | 90,922,654 | Jun 30, 2024 |
| MELQART ASSET MANAGEMENT (UK) LTD | 1.64% | 7.51% | 1,675,785 | 692,390 | 70.41% | 90,794,031 | Jun 30, 2024 |
Cytokinetics's largest institutional shareholder is BLACKROCK INC., holding 14.40% of the company's total share outstanding, currently valued at $794.97M. The top 10 institutional shareholders own together 72.84% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RP MANAGEMENT, LLC | 0.96% | 29.71% | 980,392 | 980,392 | 100.00% | 53,117,639 | Jun 30, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 4.49% | 28.63% | 4,575,558 | 4,575,558 | 100.00% | 246,073,509 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.18% | 12.81% | 187,633 | -91,282 | -32.73% | 10,165,956 | Jun 30, 2024 |
| SARISSA CAPITAL MANAGEMENT LP | 1.09% | 10.15% | 1,110,000 | 810,000 | 270.00% | 60,139,800 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.84% | 8.73% | 853,862 | 534,352 | 167.24% | 46,262,243 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 2.04% | 8.38% | 2,075,000 | -75,000 | -3.49% | 112,423,500 | Jun 30, 2024 |
| MELQART ASSET MANAGEMENT (UK) LTD | 1.64% | 7.51% | 1,675,785 | 692,390 | 70.41% | 90,794,031 | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | 0.19% | 6.21% | 190,000 | - | - | 10,294,200 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 2.06% | 5.99% | 2,100,000 | - | - | 113,778,000 | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 0.27% | 5.57% | 272,036 | 8,335 | 3.16% | 14,738,910 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.39% | 5.15% | 398,100 | - | - | 21,569,058 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.98% | 5.15% | 1,000,000 | 550,000 | 122.22% | 54,180,000 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 0.47% | 4.92% | 474,202 | 272,000 | 134.52% | 25,692,264 | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | 1.72% | 4.71% | 1,757,192 | - | - | 95,204,663 | Jun 30, 2024 |
| FINEPOINT CAPITAL LP | 0.25% | 3.94% | 256,449 | 18,403 | 7.73% | 13,894,407 | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.23% | 3.87% | 236,900 | 236,900 | 100.00% | 12,835,242 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 0.23% | 3.72% | 230,000 | -15,000 | -6.12% | 12,461,400 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.38% | 2.84% | 384,924 | 103,253 | 36.66% | 20,855,182 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.29% | 2.59% | 293,318 | -137,031 | -31.84% | 15,891,969 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.19% | 2.46% | 198,500 | 198,500 | 100.00% | 10,754,730 | Jun 30, 2024 |
The largest Cytokinetics shareholder by % of total assets is RP MANAGEMENT, LLC. The company owns 980.39K shares of Cytokinetics (CYTK), representing 29.71% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DARWIN GLOBAL MANAGEMENT, LTD. | 4.49% | 28.63% | 4,575,558 | 4,575,558 | 100.00% | 246,073,509 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 7.37% | 0.07% | 7,509,530 | 3,528,070 | 88.61% | 406,866,335 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 7.99% | 0.28% | 8,138,677 | 3,017,088 | 58.91% | 440,954,000 | Jun 30, 2024 |
| BLACKROCK INC. | 14.40% | 0.02% | 14,672,779 | 2,258,006 | 18.19% | 794,971,166 | Jun 30, 2024 |
| STATE STREET CORP | 6.42% | 0.02% | 6,548,536 | 2,028,178 | 44.87% | 354,799,680,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 11.22% | 0.01% | 11,437,696 | 1,440,620 | 14.41% | 619,694,370 | Jun 30, 2024 |
| RP MANAGEMENT, LLC | 0.96% | 29.71% | 980,392 | 980,392 | 100.00% | 53,117,639 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 2.41% | 0.78% | 2,454,665 | 849,089 | 52.88% | 132,993,750 | Jun 30, 2024 |
| SARISSA CAPITAL MANAGEMENT LP | 1.09% | 10.15% | 1,110,000 | 810,000 | 270.00% | 60,139,800 | Jun 30, 2024 |
| NORGES BANK | 0.78% | 0.01% | 799,664 | 799,664 | 100.00% | 43,325,796 | Jun 30, 2024 |
| MELQART ASSET MANAGEMENT (UK) LTD | 1.64% | 7.51% | 1,675,785 | 692,390 | 70.41% | 90,794,031 | Jun 30, 2024 |
| FMR LLC | 11.31% | 0.04% | 11,523,128 | 621,985 | 5.71% | 624,323,102 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.98% | 5.15% | 1,000,000 | 550,000 | 122.22% | 54,180,000 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 2.03% | 1.41% | 2,065,991 | 540,303 | 35.41% | 111,935,392 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.84% | 8.73% | 853,862 | 534,352 | 167.24% | 46,262,243 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.69% | 0.01% | 2,738,646 | 491,481 | 21.87% | 148,408,055 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.12% | 0.01% | 1,138,154 | 446,705 | 64.60% | 61,665,184 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.09% | 0.00% | 1,111,943 | 423,839 | 61.60% | 60,245,072 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 0.98% | 0.68% | 1,000,000 | 300,000 | 42.86% | 54,180,000 | Jun 30, 2024 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0.27% | 0.00% | 276,067 | 276,067 | 100.00% | 14,957,310 | Jun 30, 2024 |
As of Jun 30 2024, Cytokinetics's largest institutional buyer is DARWIN GLOBAL MANAGEMENT, LTD.. The company purchased 4.58M stocks of CYTK, valued at $246.07M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP | 1.65% | 0.12% | 1,678,159 | -878,644 | -34.36% | 90,922,654 | Jun 30, 2024 |
| INVESCO LTD. | 0.49% | 0.01% | 495,398 | -822,140 | -62.40% | 26,840,664 | Jun 30, 2024 |
| HAP TRADING, LLC | 0.06% | 0.33% | 60,500 | -801,800 | -92.98% | 2,784,075 | Jun 30, 2024 |
| MELQART ASSET MANAGEMENT (UK) LTD | - | - | - | -800,100 | -100.00% | - | Jun 30, 2024 |
| HAP TRADING, LLC | 0.10% | 0.02% | 102,600 | -786,400 | -88.46% | 201,088 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.20% | 0.17% | 200,000 | -603,500 | -75.11% | 10,836,000 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.31% | 0.02% | 2,358,343 | -572,605 | -19.54% | 127,776,000 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -519,918 | -100.00% | - | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 0.02% | 0.00% | 20,000 | -490,000 | -96.08% | 57,999 | Jun 30, 2024 |
| BARCLAYS PLC | 0.28% | 0.00% | 282,378 | -479,869 | -62.95% | 15,300,000 | Jun 30, 2024 |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | - | - | - | -461,018 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -430,821 | -100.00% | - | Jun 30, 2024 |
| NOMURA HOLDINGS INC | 0.12% | 0.01% | 125,000 | -400,000 | -76.19% | 6,772,500 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 4.30% | 0.02% | 4,380,769 | -396,859 | -8.31% | 237,350,064 | Jun 30, 2024 |
| HAP TRADING, LLC | - | - | - | -395,529 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.08% | 0.07% | 83,700 | -392,200 | -82.41% | 4,534,866 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.07% | 0.00% | 70,000 | -329,700 | -82.49% | 3,792,600 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.18% | 0.06% | 179,200 | -313,829 | -63.65% | 9,708,603 | Jun 30, 2024 |
| IRON TRIANGLE PARTNERS LP | - | - | - | -300,000 | -100.00% | - | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -284,700 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Cytokinetics's biggest institutional seller is MARSHALL WACE, LLP. The company sold -0.88M shares of CYTK, valued at $90.92M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RP MANAGEMENT, LLC | 0.96% | 29.71% | 980,392 | 980,392 | 100.00% | 53,117,639 | Jun 30, 2024 |
| NORGES BANK | 0.78% | 0.01% | 799,664 | 799,664 | 100.00% | 43,325,796 | Jun 30, 2024 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0.27% | 0.00% | 276,067 | 276,067 | 100.00% | 14,957,310 | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.23% | 3.87% | 236,900 | 236,900 | 100.00% | 12,835,242 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.20% | 0.06% | 204,245 | 204,245 | 100.00% | 11,065,994 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.19% | 2.46% | 198,500 | 198,500 | 100.00% | 10,754,730 | Jun 30, 2024 |
| GHISALLO CAPITAL MANAGEMENT LLC | 0.19% | 0.75% | 196,000 | 196,000 | 100.00% | 10,619,280 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 0.13% | 0.30% | 136,878 | 136,878 | 100.00% | 7,416,050 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.12% | 0.47% | 126,877 | 126,877 | 100.00% | 6,874,196 | Jun 30, 2024 |
| IMPAX ASSET MANAGEMENT GROUP PLC | 0.12% | 0.03% | 125,000 | 125,000 | 100.00% | 6,772,500 | Jun 30, 2024 |
| SEGALL BRYANT & HAMILL, LLC | 0.07% | 0.07% | 75,398 | 75,398 | 100.00% | 4,085,064 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.06% | 0.01% | 63,659 | 63,659 | 100.00% | 3,445,057 | Jun 30, 2024 |
| TROLUCE CAPITAL ADVISORS LLC | 0.03% | 0.16% | 30,398 | 30,398 | 100.00% | 1,646,964 | Jun 30, 2024 |
| QUANTITATIVE INVESTMENT MANAGEMENT, LLC | 0.03% | 0.17% | 28,624 | 28,624 | 100.00% | 1,550,000 | Jun 30, 2024 |
| OAK RIDGE INVESTMENTS LLC | 0.02% | 0.10% | 18,488 | 18,488 | 100.00% | 1,001,680 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 0.02% | 0.06% | 16,896 | 16,896 | 100.00% | 915,425 | Jun 30, 2024 |
| EDGESTREAM PARTNERS, L.P. | 0.02% | 0.04% | 15,835 | 15,835 | 100.00% | 857,940 | Jun 30, 2024 |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 0.01% | 0.06% | 13,477 | 13,477 | 100.00% | 730,184 | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 0.01% | 0.06% | 12,506 | 12,506 | 100.00% | 677,575 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.01% | 0.12% | 12,468 | 12,468 | 100.00% | 675,516 | Jun 30, 2024 |
| TOROSO INVESTMENTS, LLC | 0.01% | 0.01% | 10,246 | 10,246 | 100.00% | 555,127 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.01% | 0.00% | 8,600 | 8,600 | 100.00% | 465,948 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.01% | 0.05% | 7,355 | 7,355 | 100.00% | 398,494 | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | 0.01% | 0.01% | 5,600 | 5,600 | 100.00% | 303,408 | Jun 30, 2024 |
| PEARL RIVER CAPITAL, LLC | 0.00% | 0.04% | 4,839 | 4,839 | 100.00% | 262,177 | Jun 30, 2024 |
| ATOM INVESTORS LP | 0.00% | 0.02% | 3,986 | 3,986 | 100.00% | 215,961 | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.11% | 3,500 | 3,500 | 100.00% | 189,630 | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.00% | 0.00% | 1,007 | 1,007 | 100.00% | 57,067 | Jun 30, 2024 |
| MANCHESTER CAPITAL MANAGEMENT LLC | 0.00% | 0.00% | 550 | 550 | 100.00% | 29,799 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 484 | 484 | 100.00% | 26,223 | Jun 30, 2024 |
| RONALD BLUE TRUST, INC. | 0.00% | 0.00% | 301 | 301 | 100.00% | 21,103 | Jun 30, 2024 |
| LYNX INVESTMENT ADVISORY | 0.00% | 0.01% | 250 | 250 | 100.00% | 13,545,000 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 236 | 236 | 100.00% | 12,692 | Jun 30, 2024 |
| SYSTM WEALTH SOLUTIONS LLC | 0.00% | 0.00% | 160 | 160 | 100.00% | 8,669 | Jun 30, 2024 |
| ASHTON THOMAS PRIVATE WEALTH, LLC | 0.00% | 0.00% | 132 | 132 | 100.00% | 7,152 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 111 | 111 | 100.00% | 6,014 | Jun 30, 2024 |
| BELLEVUE ASSET MANAGEMENT, LLC | - | 0.00% | 19 | 19 | 100.00% | 1,029 | Jun 30, 2024 |
| DINUZZO PRIVATE WEALTH, INC. | - | 0.00% | 8 | 8 | 100.00% | 434 | Jun 30, 2024 |
Cytokinetics's largest new institutional shareholder by number of shares is RP MANAGEMENT, LLC, purchased 980.39K shares, valued at $53.12M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MELQART ASSET MANAGEMENT (UK) LTD | - | - | - | -800,100 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -519,918 | -100.00% | - | Jun 30, 2024 |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | - | - | - | -461,018 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -430,821 | -100.00% | - | Jun 30, 2024 |
| HAP TRADING, LLC | - | - | - | -395,529 | -100.00% | - | Jun 30, 2024 |
| IRON TRIANGLE PARTNERS LP | - | - | - | -300,000 | -100.00% | - | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -284,700 | -100.00% | - | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | - | - | - | -198,158 | -100.00% | - | Jun 30, 2024 |
| EAGLE ASSET MANAGEMENT INC | - | - | - | -195,449 | -100.00% | - | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | - | - | - | -194,000 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -188,200 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -178,309 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -176,072 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -175,300 | -100.00% | - | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | - | - | - | -166,000 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -151,800 | -100.00% | - | Jun 30, 2024 |
| KRYGER CAPITAL LTD | - | - | - | -146,838 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -105,662 | -100.00% | - | Jun 30, 2024 |
| HBK INVESTMENTS L P | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| FOURWORLD CAPITAL MANAGEMENT LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| EMERALD ADVISERS, LLC | - | - | - | -91,561 | -100.00% | - | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | - | - | - | -89,525 | -100.00% | - | Jun 30, 2024 |
| FORA CAPITAL, LLC | - | - | - | -82,776 | -100.00% | - | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | - | - | - | -80,000 | -100.00% | - | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | - | - | - | -75,000 | -100.00% | - | Jun 30, 2024 |
| EMERALD MUTUAL FUND ADVISERS TRUST | - | - | - | -72,080 | -100.00% | - | Jun 30, 2024 |
| ATIKA CAPITAL MANAGEMENT LLC | - | - | - | -70,000 | -100.00% | - | Jun 30, 2024 |
| BRIDGER MANAGEMENT, LLC | - | - | - | -69,110 | -100.00% | - | Jun 30, 2024 |
| ONE FIN CAPITAL MANAGEMENT LP | - | - | - | -53,438 | -100.00% | - | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -49,770 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -48,604 | -100.00% | - | Jun 30, 2024 |
| SANDLER CAPITAL MANAGEMENT | - | - | - | -46,000 | -100.00% | - | Jun 30, 2024 |
| EAM GLOBAL INVESTORS LLC | - | - | - | -44,612 | -100.00% | - | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -40,625 | -100.00% | - | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -37,500 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -36,554 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -35,500 | -100.00% | - | Jun 30, 2024 |
| WALLEYE TRADING LLC | - | - | - | -32,400 | -100.00% | - | Jun 30, 2024 |
| EISLER CAPITAL (US) LLC | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| DRW SECURITIES, LLC | - | - | - | -26,900 | -100.00% | - | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -26,700 | -100.00% | - | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -26,008 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -25,700 | -100.00% | - | Jun 30, 2024 |
| APIS CAPITAL ADVISORS, LLC | - | - | - | -25,200 | -100.00% | - | Jun 30, 2024 |
| TORNO CAPITAL, LLC | - | - | - | -25,000 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -24,089 | -100.00% | - | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | - | - | - | -23,394 | -100.00% | - | Jun 30, 2024 |
| CASTLEARK MANAGEMENT LLC | - | - | - | -20,980 | -100.00% | - | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | - | - | - | -20,404 | -100.00% | - | Jun 30, 2024 |
| NOMURA ASSET MANAGEMENT CO LTD | - | - | - | -20,208 | -100.00% | - | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | - | - | - | -20,160 | -100.00% | - | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -19,433 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -18,300 | -100.00% | - | Jun 30, 2024 |
| XR SECURITIES LLC | - | - | - | -18,200 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -16,023 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -14,990 | -100.00% | - | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | - | - | - | -14,979 | -100.00% | - | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | - | - | - | -14,437 | -100.00% | - | Jun 30, 2024 |
| HEALTHINVEST PARTNERS AB | - | - | - | -14,000 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -13,965 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -11,400 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -11,390 | -100.00% | - | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -9,700 | -100.00% | - | Jun 30, 2024 |
| CANNON GLOBAL INVESTMENT MANAGEMENT, LLC | - | - | - | -9,700 | -100.00% | - | Jun 30, 2024 |
| TEZA CAPITAL MANAGEMENT LLC | - | - | - | -7,952 | -100.00% | - | Jun 30, 2024 |
| CERITY PARTNERS LLC | - | - | - | -7,465 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -7,400 | -100.00% | - | Jun 30, 2024 |
| SHAY CAPITAL LLC | - | - | - | -7,300 | -100.00% | - | Jun 30, 2024 |
| SEVEN EIGHT CAPITAL, LP | - | - | - | -6,935 | -100.00% | - | Jun 30, 2024 |
| CANTOR FITZGERALD, L. P. | - | - | - | -6,030 | -100.00% | - | Jun 30, 2024 |
| BRIDGEFRONT CAPITAL, LLC | - | - | - | -5,691 | -100.00% | - | Jun 30, 2024 |
| CORTON CAPITAL INC. | - | - | - | -5,588 | -100.00% | - | Jun 30, 2024 |
| POINT72 HONG KONG LTD | - | - | - | -5,345 | -100.00% | - | Jun 30, 2024 |
| INCEPTIONR LLC | - | - | - | -5,246 | -100.00% | - | Jun 30, 2024 |
| CLARIVEST ASSET MANAGEMENT LLC | - | - | - | -5,086 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -5,082 | -100.00% | - | Jun 30, 2024 |
| HARVEST MANAGEMENT LLC | - | - | - | -5,000 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -5,000 | -100.00% | - | Jun 30, 2024 |
| KNOTT DAVID M JR | - | - | - | -5,000 | -100.00% | - | Jun 30, 2024 |
| EVERGREEN CAPITAL MANAGEMENT LLC | - | - | - | -4,163 | -100.00% | - | Jun 30, 2024 |
| CHARTWELL INVESTMENT PARTNERS, LLC | - | - | - | -4,013 | -100.00% | - | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -3,469 | -100.00% | - | Jun 30, 2024 |
| ORION PORTFOLIO SOLUTIONS, LLC | - | - | - | -3,168 | -100.00% | - | Jun 30, 2024 |
| CI PRIVATE WEALTH, LLC | - | - | - | -3,165 | -100.00% | - | Jun 30, 2024 |
| CIM INVESTMENT MANAGEMENT INC | - | - | - | -3,156 | -100.00% | - | Jun 30, 2024 |
| HC ADVISORS, LLC | - | - | - | -3,083 | -100.00% | - | Jun 30, 2024 |
| PINNACLE WEALTH PLANNING SERVICES, INC. | - | - | - | -3,015 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -2,993 | -100.00% | - | Jun 30, 2024 |
| EQIS CAPITAL MANAGEMENT, INC. | - | - | - | -2,963 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -1,593 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -1,050 | -100.00% | - | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | - | - | - | -55 | -100.00% | - | Jun 30, 2024 |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | - | - | - | -7 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -2 | -100.00% | - | Jun 30, 2024 |
Cytokinetics's largest sold out institutional shareholder by shares sold is MELQART ASSET MANAGEMENT (UK) LTD, sold -0.80M shares, valued at -, as of undefined.
Cytokinetics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Manager Directed Portfolios | 1.74% | 285,394 | - | - | Jan 31, 2024 |
| TRI-CONTINENTAL CORP | 0.74% | 4,000,000 | - | - | Mar 31, 2024 |
| Virtus Equity & Convertible Income Fund | 0.71% | 1,405,000 | - | - | Jan 31, 2024 |
| Virtus Dividend, Interest & Premium Strategy Fund | 0.67% | 1,580,000 | - | - | Jan 31, 2024 |
| Virtus Diversified Income & Convertible Fund | 0.56% | 1,130,000 | - | - | Jan 31, 2024 |
| BANCROFT FUND LTD | 0.54% | 750,000 | 750,000 | - | Dec 29, 2023 |
| ELLSWORTH GROWTH & INCOME FUND LTD | 0.53% | 750,000 | 750,000 | - | Dec 29, 2023 |
| GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC | 0.50% | 400,000 | 400,000 | - | Dec 29, 2023 |
| TRI-CONTINENTAL CORP | 0.46% | 2,500,000 | - | - | Mar 31, 2024 |
| PUTNAM CONVERTIBLE SECURITIES FUND | 0.46% | 2,260,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund II | 0.45% | 1,680,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund | 0.44% | 2,190,000 | - | - | Jan 31, 2024 |
| Tema ETF Trust | 0.41% | 18,408 | 12,909 | 234.75% | Feb 29, 2024 |
| ADVENT CONVERTIBLE & INCOME FUND | 0.39% | 1,325,000 | - | - | Jan 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.38% | 92,882 | -7,669 | -7.63% | Dec 31, 2023 |
| ADVENT CONVERTIBLE & INCOME FUND | 0.29% | 1,008,000 | -317,000 | -23.92% | Jan 31, 2024 |
| FIDELITY FINANCIAL TRUST | 0.28% | 5,101,000 | 5,101,000 | - | Feb 29, 2024 |
| Virtus Equity & Convertible Income Fund | 0.27% | 540,000 | 540,000 | - | Jan 31, 2024 |
| Virtus Dividend, Interest & Premium Strategy Fund | 0.27% | 635,000 | 635,000 | - | Jan 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.26% | 938,700 | 223,900 | 31.32% | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.25% | 1,240,227 | 82,012 | 7.08% | Mar 31, 2024 |
| Virtus Diversified Income & Convertible Fund | 0.23% | 460,000 | 460,000 | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.21% | 1,805,171 | -115,400 | -6.01% | Jan 31, 2024 |
| SPDR S&P MIDCAP 400 ETF TRUST | 0.20% | 801,687 | 801,687 | - | Mar 28, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.19% | 395,827 | - | - | Feb 29, 2024 |
| Virtus Strategy Trust | 0.17% | 3,700,000 | - | - | Mar 28, 2024 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.17% | 154,520 | -397,470 | -72.01% | Jan 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.16% | 525,400 | 50,300 | 10.59% | Mar 31, 2024 |
| TETON WESTWOOD FUNDS | 0.15% | 100,000 | 100,000 | - | Dec 29, 2023 |
| Virtus Convertible & Income Fund II | 0.15% | 575,000 | 575,000 | - | Jan 31, 2024 |
| AB DISCOVERY GROWTH FUND, INC. | 0.15% | 223,117 | 223,117 | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund | 0.15% | 725,000 | 725,000 | - | Jan 31, 2024 |
| Virtus Strategy Trust | 0.14% | 2,935,000 | -1,390,000 | -32.14% | Mar 28, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.14% | 117,519 | 31,671 | 36.89% | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.14% | 64,623 | 20,211 | 45.51% | Mar 31, 2024 |
| VANGUARD ADMIRAL FUNDS | 0.14% | 594,118 | 91,611 | 18.23% | Feb 29, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.13% | 447,350 | -363,325 | -44.82% | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.12% | 64,453 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.10% | 276,900 | - | - | Mar 31, 2024 |
| BNY MELLON INDEX FUNDS, INC. | 0.09% | 99,461 | -11,564 | -10.42% | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.08% | 228,000 | -37,000 | -13.96% | Mar 31, 2024 |
| BNY MELLON INVESTMENT PORTFOLIOS | 0.08% | 48,922 | - | - | Mar 31, 2024 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 0.07% | 998,900 | 998,900 | - | Mar 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.06% | 2,000,000 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.06% | 16,280 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.06% | 503,900 | 175,500 | 53.44% | Mar 31, 2024 |
| LORD ABBETT RESEARCH FUND INC | 0.06% | 58,586 | - | - | Feb 29, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.06% | 614,752 | 300,700 | 95.75% | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.05% | 560,128 | -560,058 | -50.00% | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.04% | 483,355 | -46,000 | -8.69% | Jan 31, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.04% | 5,067 | - | - | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.04% | 54,226 | 3,426 | 6.74% | Feb 29, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.04% | 13,228 | -633 | -4.57% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.04% | 2,341,721 | -359,250 | -13.30% | Feb 29, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.03% | 346,402 | -2,377,927 | -87.28% | Jan 31, 2024 |
| Humankind Benefit Corp | 0.03% | 747 | 2 | 0.27% | Dec 31, 2023 |
| WANGER ADVISORS TRUST | 0.03% | 17,738 | 17,738 | - | Mar 31, 2024 |
| COLUMBIA ACORN TRUST | 0.03% | 93,217 | 93,217 | - | Mar 31, 2024 |
| WASATCH FUNDS TRUST | 0.03% | 252,009 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 167,454 | -2,136 | -1.26% | Mar 31, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.03% | 1,469,555 | -1,864,975 | -55.93% | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.03% | 30,000 | 30,000 | - | Mar 28, 2024 |
| Tekla Healthcare Opportunities Fund | 0.03% | 57,100 | 57,100 | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.03% | 229,000 | - | - | Mar 28, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.02% | 40,656 | 1,483 | 3.79% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 14,190 | -99 | -0.69% | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.02% | 199,224 | -354,200 | -64.00% | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,896,313 | -76,747 | -3.89% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.02% | 8,489,122 | -1,495,897 | -14.98% | Mar 31, 2024 |
| AMERICAN CENTURY VARIABLE PORTFOLIOS INC | 0.02% | 48,209 | - | - | Mar 31, 2024 |
| Columbia Funds Series Trust II | 0.02% | 7,000,000 | - | - | Jan 31, 2024 |
| ALGER FUNDS | 0.02% | 16,970 | 16,970 | - | Jan 31, 2024 |
| Columbia Funds Series Trust II | 0.02% | 6,500,000 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.02% | 133,200 | -76,900 | -36.60% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.01% | 317,931 | -57,900 | -15.41% | Mar 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.01% | 6,850 | - | - | Mar 31, 2024 |
| AB CAP FUND, INC. | 0.01% | 438,240 | 438,240 | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.01% | 9,860 | 9,860 | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.01% | 31,003 | 21,622 | 230.49% | Mar 31, 2024 |
| AIM FUNDS GROUP (INVESCO FUNDS GROUP) | 0.01% | 58,204 | 58,204 | - | Mar 31, 2024 |
| FORUM FUNDS II | 0.01% | 10,800 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 32,758 | 527 | 1.64% | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,182 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.01% | 37,661 | -20,936 | -35.73% | Jan 31, 2024 |
| Vericimetry Funds | 0.01% | 820 | - | - | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.01% | 450,000 | -50,000 | -10.00% | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.01% | 164,500 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.01% | 18,000 | - | - | Mar 31, 2024 |
| ALLSPRING VARIABLE TRUST | 0.01% | 4,491 | - | - | Mar 31, 2024 |
| Bernstein Fund Inc | 0.01% | 61,690 | 22,110 | 55.86% | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.01% | 1,325,083 | -341,019 | -20.47% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.01% | 29,771 | -3,526 | -10.59% | Dec 31, 2023 |
| SYNTAX ETF TRUST | 0.01% | 215 | -556 | -72.11% | Mar 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.01% | 202,042 | 21,492 | 11.90% | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.01% | 36,879 | - | - | Mar 31, 2020 |
| SCHWAB CAPITAL TRUST | 0.01% | 260,441 | 2,043 | 0.79% | Jan 31, 2024 |
| Brown Advisory Funds | 0.01% | 224,923 | 224,923 | - | Mar 31, 2024 |
| ADVENT CONVERTIBLE & INCOME FUND | 0.01% | 20,000 | 20,000 | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.01% | 63,110 | - | - | Feb 29, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 40,389 | - | - | Mar 28, 2024 |
Cytokinetics's largest mutual fund holder by % of total assets is "Manager Directed Portfolios", owning 285.39K shares, compromising 1.74% of its total assets.
Cytokinetics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 217 | -52.10% |
| 31 Mar, 24 | 453 | 6.59% |
| 31 Dec, 23 | 425 | 52.88% |
| 30 Sep, 23 | 278 | 4.91% |
| 30 Jun, 23 | 265 | -1.49% |
| 31 Mar, 23 | 269 | -7.56% |
| 31 Dec, 22 | 291 | 0.34% |
| 30 Sep, 22 | 290 | 4.69% |
| 30 Jun, 22 | 277 | 13.06% |
| 31 Mar, 22 | 245 | -4.30% |
| 31 Dec, 21 | 256 | 15.32% |
| 30 Sep, 21 | 222 | 13.85% |
| 30 Jun, 21 | 195 | -2.01% |
| 31 Mar, 21 | 199 | 2.58% |
| 31 Dec, 20 | 194 | -5.83% |
| 30 Sep, 20 | 206 | 22.62% |
| 30 Jun, 20 | 168 | 8.39% |
| 31 Mar, 20 | 155 | 6.16% |
| 31 Dec, 19 | 146 | -2.67% |
| 30 Sep, 19 | 150 | 8.70% |
| 30 Jun, 19 | 138 | 1.47% |
| 31 Mar, 19 | 136 | 2.26% |
| 31 Dec, 18 | 133 | 10.83% |
| 30 Sep, 18 | 120 | -4.76% |
| 30 Jun, 18 | 126 | -0.79% |
| 31 Mar, 18 | 127 | -5.93% |
| 31 Dec, 17 | 135 | -4.26% |
| 30 Sep, 17 | 141 | 0.71% |
| 30 Jun, 17 | 140 | 27.27% |
| 31 Mar, 17 | 110 | 4.76% |
| 31 Dec, 16 | 105 | 9.38% |
| 30 Sep, 16 | 96 | -3.03% |
| 30 Jun, 16 | 99 | -11.61% |
| 31 Mar, 16 | 112 | -13.18% |
| 31 Dec, 15 | 129 | 18.35% |
| 30 Sep, 15 | 109 | 4.81% |
| 30 Jun, 15 | 104 | 8.33% |
| 31 Mar, 15 | 96 | 7.87% |
| 31 Dec, 14 | 89 | - |
| 30 Sep, 14 | 89 | -9.18% |
| 30 Jun, 14 | 98 | -24.03% |
| 31 Mar, 14 | 129 | 38.71% |
| 31 Dec, 13 | 93 | -8.82% |
| 30 Sep, 13 | 102 | 436.84% |
| 30 Jun, 13 | 19 | - |
As of 30 Jun 24, 217 institutions are holding Cytokinetics's shares, representing a decrease of -52.10% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 60,225,729 | -48.37% |
| 31 Mar, 24 | 116,652,886 | 2.18% |
| 31 Dec, 23 | 114,167,253 | 4.60% |
| 30 Sep, 23 | 109,148,854 | 0.82% |
| 30 Jun, 23 | 108,258,429 | -0.57% |
| 31 Mar, 23 | 108,880,472 | 2.44% |
| 31 Dec, 22 | 106,291,575 | 1.63% |
| 30 Sep, 22 | 104,588,940 | -1.28% |
| 30 Jun, 22 | 105,950,061 | 10.94% |
| 31 Mar, 22 | 95,502,382 | 4.54% |
| 31 Dec, 21 | 91,357,928 | 1.24% |
| 30 Sep, 21 | 90,243,266 | 19.37% |
| 30 Jun, 21 | 75,598,221 | 1.02% |
| 31 Mar, 21 | 74,832,171 | 2.61% |
| 31 Dec, 20 | 72,928,371 | 5.75% |
| 30 Sep, 20 | 68,963,309 | 19.10% |
| 30 Jun, 20 | 57,903,994 | 3.90% |
| 31 Mar, 20 | 55,733,085 | 1.29% |
| 31 Dec, 19 | 55,024,044 | 23.73% |
| 30 Sep, 19 | 44,469,698 | 1.62% |
| 30 Jun, 19 | 43,758,825 | 11.77% |
| 31 Mar, 19 | 39,150,066 | -1.52% |
| 31 Dec, 18 | 39,752,861 | 2.88% |
| 30 Sep, 18 | 38,641,650 | 3.05% |
| 30 Jun, 18 | 37,498,399 | 1.67% |
| 31 Mar, 18 | 36,881,082 | -4.03% |
| 31 Dec, 17 | 38,427,820 | -2.80% |
| 30 Sep, 17 | 39,533,337 | 3.39% |
| 30 Jun, 17 | 38,237,390 | 35.02% |
| 31 Mar, 17 | 28,319,546 | 7.10% |
| 31 Dec, 16 | 26,441,546 | -0.90% |
| 30 Sep, 16 | 26,681,549 | 0.53% |
| 30 Jun, 16 | 26,540,002 | -0.34% |
| 31 Mar, 16 | 26,629,239 | 0.89% |
| 31 Dec, 15 | 26,395,353 | 22.28% |
| 30 Sep, 15 | 21,585,407 | 4.02% |
| 30 Jun, 15 | 20,750,679 | 5.96% |
| 31 Mar, 15 | 19,584,385 | 1.45% |
| 31 Dec, 14 | 19,304,649 | -2.56% |
| 30 Sep, 14 | 19,811,110 | -5.84% |
| 30 Jun, 14 | 21,040,201 | -6.82% |
| 31 Mar, 14 | 22,581,082 | 23.18% |
| 31 Dec, 13 | 18,331,992 | 1.59% |
| 30 Sep, 13 | 18,045,345 | 568.32% |
| 30 Jun, 13 | 2,700,109 | - |
Cytokinetics (CYTK) has 60.23M shares outstanding as of 30 Jun 24, down -48.37% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 59.09% | 0.45% |
| 31 Mar, 24 | 114.45% | 0.82% |
| 31 Dec, 23 | 118.28% | 0.92% |
| 30 Sep, 23 | 113.61% | 0.89% |
| 30 Jun, 23 | 113.06% | 0.86% |
| 31 Mar, 23 | 114.41% | 0.82% |
| 31 Dec, 22 | 118.33% | 0.95% |
| 30 Sep, 22 | 111.55% | 0.73% |
| 30 Jun, 22 | 123.58% | 0.98% |
| 31 Mar, 22 | 112.36% | 0.95% |
| 31 Dec, 21 | 108.94% | 0.86% |
| 30 Sep, 21 | 112.68% | 1.02% |
| 30 Jun, 21 | 105.36% | 0.95% |
| 31 Mar, 21 | 105.11% | 0.99% |
| 31 Dec, 20 | 102.96% | 1.01% |
| 30 Sep, 20 | 101.00% | 1.07% |
| 30 Jun, 20 | 97.15% | 1.10% |
| 31 Mar, 20 | 94.03% | 1.09% |
| 31 Dec, 19 | 93.02% | 1.62% |
| 30 Sep, 19 | 75.84% | 1.32% |
| 30 Jun, 19 | 75.91% | 1.49% |
| 31 Mar, 19 | 71.41% | 1.34% |
| 31 Dec, 18 | 73.05% | 1.46% |
| 30 Sep, 18 | 70.74% | 1.48% |
| 30 Jun, 18 | 69.07% | 1.48% |
| 31 Mar, 18 | 68.22% | 1.13% |
| 31 Dec, 17 | 77.78% | 1.44% |
| 30 Sep, 17 | 73.59% | 1.17% |
| 30 Jun, 17 | 79.30% | 1.71% |
| 31 Mar, 17 | 68.11% | 1.55% |
| 31 Dec, 16 | 66.20% | 1.48% |
| 30 Sep, 16 | 66.83% | 1.49% |
| 30 Jun, 16 | 66.91% | 1.48% |
| 31 Mar, 16 | 67.26% | 1.44% |
| 31 Dec, 15 | 68.27% | 2.17% |
| 30 Sep, 15 | 56.10% | 1.95% |
| 30 Jun, 15 | 53.58% | 2.09% |
| 31 Mar, 15 | 50.64% | 1.83% |
| 31 Dec, 14 | 52.53% | 1.79% |
| 30 Sep, 14 | 54.12% | 1.62% |
| 30 Jun, 14 | 57.73% | 1.23% |
| 31 Mar, 14 | 68.46% | 1.81% |
| 31 Dec, 13 | 61.44% | 1.63% |
| 30 Sep, 13 | 61.39% | 55.93% |
| 30 Jun, 13 | 10.48% | - |
As of 30 Jun 24, Cytokinetics is held by 59.09% institutional shareholders, representing a 0.45% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 116 | -48.67% |
| 31 Mar, 24 | 226 | 10.24% |
| 31 Dec, 23 | 205 | 66.67% |
| 30 Sep, 23 | 123 | -3.91% |
| 30 Jun, 23 | 128 | 7.56% |
| 31 Mar, 23 | 119 | -19.05% |
| 31 Dec, 22 | 147 | -3.92% |
| 30 Sep, 22 | 153 | 1.32% |
| 30 Jun, 22 | 151 | 24.79% |
| 31 Mar, 22 | 121 | -9.02% |
| 31 Dec, 21 | 133 | -8.28% |
| 30 Sep, 21 | 145 | 62.92% |
| 30 Jun, 21 | 89 | -3.26% |
| 31 Mar, 21 | 92 | -5.15% |
| 31 Dec, 20 | 97 | -24.22% |
| 30 Sep, 20 | 128 | 40.66% |
| 30 Jun, 20 | 91 | 9.64% |
| 31 Mar, 20 | 83 | 5.06% |
| 31 Dec, 19 | 79 | 9.72% |
| 30 Sep, 19 | 72 | -17.24% |
| 30 Jun, 19 | 87 | 12.99% |
| 31 Mar, 19 | 77 | 8.45% |
| 31 Dec, 18 | 71 | 20.34% |
| 30 Sep, 18 | 59 | 1.72% |
| 30 Jun, 18 | 58 | 7.41% |
| 31 Mar, 18 | 54 | -15.63% |
| 31 Dec, 17 | 64 | -7.25% |
| 30 Sep, 17 | 69 | -27.37% |
| 30 Jun, 17 | 95 | 50.79% |
| 31 Mar, 17 | 63 | 26.00% |
| 31 Dec, 16 | 50 | 6.38% |
| 30 Sep, 16 | 47 | 46.88% |
| 30 Jun, 16 | 32 | -25.58% |
| 31 Mar, 16 | 43 | -43.42% |
| 31 Dec, 15 | 76 | 38.18% |
| 30 Sep, 15 | 55 | -1.79% |
| 30 Jun, 15 | 56 | 7.69% |
| 31 Mar, 15 | 52 | 23.81% |
| 31 Dec, 14 | 42 | -4.55% |
| 30 Sep, 14 | 44 | -21.43% |
| 30 Jun, 14 | 56 | -28.21% |
| 31 Mar, 14 | 78 | 59.18% |
| 31 Dec, 13 | 49 | -47.31% |
| 30 Sep, 13 | 93 | 416.67% |
| 30 Jun, 13 | 18 | - |
116 institutional shareholders have increased their position in CYTK stock as of 30 Jun 24 compared to 226 in the previous quarter (a -48.67% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 59 | -54.96% |
| 31 Mar, 24 | 131 | 11.97% |
| 31 Dec, 23 | 117 | 46.25% |
| 30 Sep, 23 | 80 | - |
| 30 Jun, 23 | 80 | -19.19% |
| 31 Mar, 23 | 99 | 16.47% |
| 31 Dec, 22 | 85 | - |
| 30 Sep, 22 | 85 | 11.84% |
| 30 Jun, 22 | 76 | -8.43% |
| 31 Mar, 22 | 83 | 5.06% |
| 31 Dec, 21 | 79 | 75.56% |
| 30 Sep, 21 | 45 | -30.77% |
| 30 Jun, 21 | 65 | - |
| 31 Mar, 21 | 65 | 6.56% |
| 31 Dec, 20 | 61 | 56.41% |
| 30 Sep, 20 | 39 | -23.53% |
| 30 Jun, 20 | 51 | 27.50% |
| 31 Mar, 20 | 40 | 8.11% |
| 31 Dec, 19 | 37 | -5.13% |
| 30 Sep, 19 | 39 | 85.71% |
| 30 Jun, 19 | 21 | -19.23% |
| 31 Mar, 19 | 26 | -27.78% |
| 31 Dec, 18 | 36 | 9.09% |
| 30 Sep, 18 | 33 | -15.38% |
| 30 Jun, 18 | 39 | -4.88% |
| 31 Mar, 18 | 41 | -10.87% |
| 31 Dec, 17 | 46 | 15.00% |
| 30 Sep, 17 | 40 | 48.15% |
| 30 Jun, 17 | 27 | - |
| 31 Mar, 17 | 27 | -20.59% |
| 31 Dec, 16 | 34 | 61.90% |
| 30 Sep, 16 | 21 | -48.78% |
| 30 Jun, 16 | 41 | - |
| 31 Mar, 16 | 41 | 10.81% |
| 31 Dec, 15 | 37 | 15.63% |
| 30 Sep, 15 | 32 | 10.34% |
| 30 Jun, 15 | 29 | - |
| 31 Mar, 15 | 29 | 3.57% |
| 31 Dec, 14 | 28 | 86.67% |
| 30 Sep, 14 | 15 | -34.78% |
| 30 Jun, 14 | 23 | -14.81% |
| 31 Mar, 14 | 27 | 3.85% |
| 31 Dec, 13 | 26 | 766.67% |
| 30 Sep, 13 | 3 | - |
| 30 Jun, 13 | - | - |
59 institutional shareholders have reduced their position in CYTK stock as of 30 Jun 24 compared to 131 in the previous quarter (a -54.96% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 217 | -52.10% | 60,225,729 | -48.37% | 59.09% | 0.45% | 116 | -48.67% | 59 | -54.96% |
| 31 Mar, 24 | 453 | 6.59% | 116,652,886 | 2.18% | 114.45% | 0.82% | 226 | 10.24% | 131 | 11.97% |
| 31 Dec, 23 | 425 | 52.88% | 114,167,253 | 4.60% | 118.28% | 0.92% | 205 | 66.67% | 117 | 46.25% |
| 30 Sep, 23 | 278 | 4.91% | 109,148,854 | 0.82% | 113.61% | 0.89% | 123 | -3.91% | 80 | - |
| 30 Jun, 23 | 265 | -1.49% | 108,258,429 | -0.57% | 113.06% | 0.86% | 128 | 7.56% | 80 | -19.19% |
| 31 Mar, 23 | 269 | -7.56% | 108,880,472 | 2.44% | 114.41% | 0.82% | 119 | -19.05% | 99 | 16.47% |
| 31 Dec, 22 | 291 | 0.34% | 106,291,575 | 1.63% | 118.33% | 0.95% | 147 | -3.92% | 85 | - |
| 30 Sep, 22 | 290 | 4.69% | 104,588,940 | -1.28% | 111.55% | 0.73% | 153 | 1.32% | 85 | 11.84% |
| 30 Jun, 22 | 277 | 13.06% | 105,950,061 | 10.94% | 123.58% | 0.98% | 151 | 24.79% | 76 | -8.43% |
| 31 Mar, 22 | 245 | -4.30% | 95,502,382 | 4.54% | 112.36% | 0.95% | 121 | -9.02% | 83 | 5.06% |
| 31 Dec, 21 | 256 | 15.32% | 91,357,928 | 1.24% | 108.94% | 0.86% | 133 | -8.28% | 79 | 75.56% |
| 30 Sep, 21 | 222 | 13.85% | 90,243,266 | 19.37% | 112.68% | 1.02% | 145 | 62.92% | 45 | -30.77% |
| 30 Jun, 21 | 195 | -2.01% | 75,598,221 | 1.02% | 105.36% | 0.95% | 89 | -3.26% | 65 | - |
| 31 Mar, 21 | 199 | 2.58% | 74,832,171 | 2.61% | 105.11% | 0.99% | 92 | -5.15% | 65 | 6.56% |
| 31 Dec, 20 | 194 | -5.83% | 72,928,371 | 5.75% | 102.96% | 1.01% | 97 | -24.22% | 61 | 56.41% |
| 30 Sep, 20 | 206 | 22.62% | 68,963,309 | 19.10% | 101.00% | 1.07% | 128 | 40.66% | 39 | -23.53% |
| 30 Jun, 20 | 168 | 8.39% | 57,903,994 | 3.90% | 97.15% | 1.10% | 91 | 9.64% | 51 | 27.50% |
| 31 Mar, 20 | 155 | 6.16% | 55,733,085 | 1.29% | 94.03% | 1.09% | 83 | 5.06% | 40 | 8.11% |
| 31 Dec, 19 | 146 | -2.67% | 55,024,044 | 23.73% | 93.02% | 1.62% | 79 | 9.72% | 37 | -5.13% |
| 30 Sep, 19 | 150 | 8.70% | 44,469,698 | 1.62% | 75.84% | 1.32% | 72 | -17.24% | 39 | 85.71% |
| 30 Jun, 19 | 138 | 1.47% | 43,758,825 | 11.77% | 75.91% | 1.49% | 87 | 12.99% | 21 | -19.23% |
| 31 Mar, 19 | 136 | 2.26% | 39,150,066 | -1.52% | 71.41% | 1.34% | 77 | 8.45% | 26 | -27.78% |
| 31 Dec, 18 | 133 | 10.83% | 39,752,861 | 2.88% | 73.05% | 1.46% | 71 | 20.34% | 36 | 9.09% |
| 30 Sep, 18 | 120 | -4.76% | 38,641,650 | 3.05% | 70.74% | 1.48% | 59 | 1.72% | 33 | -15.38% |
| 30 Jun, 18 | 126 | -0.79% | 37,498,399 | 1.67% | 69.07% | 1.48% | 58 | 7.41% | 39 | -4.88% |
| 31 Mar, 18 | 127 | -5.93% | 36,881,082 | -4.03% | 68.22% | 1.13% | 54 | -15.63% | 41 | -10.87% |
| 31 Dec, 17 | 135 | -4.26% | 38,427,820 | -2.80% | 77.78% | 1.44% | 64 | -7.25% | 46 | 15.00% |
| 30 Sep, 17 | 141 | 0.71% | 39,533,337 | 3.39% | 73.59% | 1.17% | 69 | -27.37% | 40 | 48.15% |
| 30 Jun, 17 | 140 | 27.27% | 38,237,390 | 35.02% | 79.30% | 1.71% | 95 | 50.79% | 27 | - |
| 31 Mar, 17 | 110 | 4.76% | 28,319,546 | 7.10% | 68.11% | 1.55% | 63 | 26.00% | 27 | -20.59% |
| 31 Dec, 16 | 105 | 9.38% | 26,441,546 | -0.90% | 66.20% | 1.48% | 50 | 6.38% | 34 | 61.90% |
| 30 Sep, 16 | 96 | -3.03% | 26,681,549 | 0.53% | 66.83% | 1.49% | 47 | 46.88% | 21 | -48.78% |
| 30 Jun, 16 | 99 | -11.61% | 26,540,002 | -0.34% | 66.91% | 1.48% | 32 | -25.58% | 41 | - |
| 31 Mar, 16 | 112 | -13.18% | 26,629,239 | 0.89% | 67.26% | 1.44% | 43 | -43.42% | 41 | 10.81% |
| 31 Dec, 15 | 129 | 18.35% | 26,395,353 | 22.28% | 68.27% | 2.17% | 76 | 38.18% | 37 | 15.63% |
| 30 Sep, 15 | 109 | 4.81% | 21,585,407 | 4.02% | 56.10% | 1.95% | 55 | -1.79% | 32 | 10.34% |
| 30 Jun, 15 | 104 | 8.33% | 20,750,679 | 5.96% | 53.58% | 2.09% | 56 | 7.69% | 29 | - |
| 31 Mar, 15 | 96 | 7.87% | 19,584,385 | 1.45% | 50.64% | 1.83% | 52 | 23.81% | 29 | 3.57% |
| 31 Dec, 14 | 89 | - | 19,304,649 | -2.56% | 52.53% | 1.79% | 42 | -4.55% | 28 | 86.67% |
| 30 Sep, 14 | 89 | -9.18% | 19,811,110 | -5.84% | 54.12% | 1.62% | 44 | -21.43% | 15 | -34.78% |
| 30 Jun, 14 | 98 | -24.03% | 21,040,201 | -6.82% | 57.73% | 1.23% | 56 | -28.21% | 23 | -14.81% |
| 31 Mar, 14 | 129 | 38.71% | 22,581,082 | 23.18% | 68.46% | 1.81% | 78 | 59.18% | 27 | 3.85% |
| 31 Dec, 13 | 93 | -8.82% | 18,331,992 | 1.59% | 61.44% | 1.63% | 49 | -47.31% | 26 | 766.67% |
| 30 Sep, 13 | 102 | 436.84% | 18,045,345 | 568.32% | 61.39% | 55.93% | 93 | 416.67% | 3 | - |
| 30 Jun, 13 | 19 | - | 2,700,109 | - | 10.48% | - | 18 | - | - | - |
Cytokinetics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Cytokinetics's stock was made by Blum Robert I on Aug 12 2024, selling 11,500 shares at $55.17 per share (valued at $634.46K).
Cytokinetics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 15 | 24 | 62.50% |
| Q2 2024 | 24 | 24 | 100.00% |
| Q1 2024 | 27 | 29 | 93.10% |
| Q4 2023 | 14 | 19 | 73.68% |
| Q3 2023 | 16 | 21 | 76.19% |
| Q2 2023 | 31 | 17 | 182.35% |
| Q1 2023 | 29 | 36 | 80.56% |
| Q4 2022 | 14 | 18 | 77.78% |
| Q3 2022 | 24 | 41 | 58.54% |
| Q2 2022 | 32 | 22 | 145.45% |
| Q1 2022 | 43 | 37 | 116.22% |
| Q4 2021 | 34 | 46 | 73.91% |
| Q3 2021 | 23 | 27 | 85.19% |
| Q2 2021 | 46 | 47 | 97.87% |
| Q1 2021 | 43 | 45 | 95.56% |
| Q4 2020 | 24 | 57 | 42.11% |
| Q3 2020 | 17 | 35 | 48.57% |
| Q2 2020 | 32 | 45 | 71.11% |
| Q1 2020 | 31 | 16 | 193.75% |
| Q4 2019 | 7 | 9 | 77.78% |
15 total buy trades, and 24 total sell trades (buy/sell ratio of 0.63%) were made by Cytokinetics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 14 | - |
| Q2 2024 | - | 17 | - |
| Q1 2024 | - | 12 | - |
| Q4 2023 | - | 10 | - |
| Q3 2023 | - | 11 | - |
| Q2 2023 | - | 10 | - |
| Q1 2023 | - | 13 | - |
| Q4 2022 | - | 10 | - |
| Q3 2022 | - | 16 | - |
| Q2 2022 | - | 10 | - |
| Q1 2022 | - | 8 | - |
| Q4 2021 | - | 19 | - |
| Q3 2021 | - | 16 | - |
| Q2 2021 | - | 24 | - |
| Q1 2021 | - | 12 | - |
| Q4 2020 | - | 22 | - |
| Q3 2020 | - | 18 | - |
| Q2 2020 | - | 18 | - |
| Q1 2020 | - | 5 | - |
| Q4 2019 | 7 | 6 | 116.67% |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 14 open market sell trades of Cytokinetics's stocks.
Cytokinetics Peer Ownership
| Ticker | Company |
|---|---|
| DICE | DICE Therapeutics, Inc. |
| PLRX | Pliant Therapeutics, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| ARVN | Arvinas, Inc. |
| DYN | Dyne Therapeutics, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| BPMC | Blueprint Medicines Corporation |
| EWTX | Edgewise Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| RLAY | Relay Therapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| KRTX | Karuna Therapeutics, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
CYTK Ownership FAQ
Who Owns Cytokinetics?
Cytokinetics is owned by institutional shareholders (59.09%), insiders (0.51%), and public (40.41%). The largest institutional shareholder of Cytokinetics is BLACKROCK INC. (14.40% of total shares) and the top mutual fund owner is Manager Directed Portfolios (1.74% of total shares).
Who are the major institutional shareholders of Cytokinetics?
Cytokinetics's major institutional shareholders are BLACKROCK INC., FMR LLC, VANGUARD GROUP INC, T. ROWE PRICE INVESTMENT MANAGEMENT, INC., and WELLINGTON MANAGEMENT GROUP LLP. The top five shareholders own together 52.28% of the company's share outstanding.
How many Cytokinetics shareholders are there?
As of Jun 2024, there are 217 institutional shareholders of Cytokinetics.
What percentage of Cytokinetics is owned by BLACKROCK INC?
BLACKROCK INC owns 14.67M shares of Cytokinetics, representing 14.40% of the company's total shares outstanding, valued at $794.97M (as of Jun 2024).
What percentage of Cytokinetics is owned by FMR LLC?
As of Jun 2024, FMR LLC holds 11.52M shares of Cytokinetics (CYTK), compromising 11.31% of the company, valued at $624.32M.
What percentage of Cytokinetics is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Cytokinetics. The company owns 11.44M of the company's shares outstanding (worth $619.69M).